MG Fraczek
Corticosteroid treatment is associated with increased filamentous fungal burden in
allergic fungal disease
Fraczek, MG; Chishimba, L; Niven, RM; Bromley, M; Simpson, A; Smyth, LJC; Denning, DW; Bowyer, P
Authors
L Chishimba
RM Niven
M Bromley
A Simpson
LJC Smyth
DW Denning
P Bowyer
Abstract
Background
Allergic diseases caused by fungi are common. The best understood conditions are allergic
bronchopulmonaryaspergillosis (ABPA) and severe asthma with fungal sensitisation (SAFS).
Our knowledge of the fungal microbiome (mycobiome) is limited to a few studies involving
healthy individuals, asthmatics and smokers. No study has yet examined the mycobiome in
fungal lung disease.
Objectives
The main aim of this study was to determine the mycobiome in lungs of individuals with well
characterised fungal disease. A secondary objective was to determine possible effects of
treatment on the mycobiome.
Methods
After bronchoscopy, ITS1 DNA was amplified and sequenced and fungal load determined by
RT-PCR. Clinical and treatment variables were correlated with the main species identified.
ABPA (n=16), SAFS (n=16), severe asthma not sensitised to fungi, (n=9), mild asthma
patients(n=7) and 10 healthy controls were studied.
Results
The mycobiome was highly varied with severe asthmatics carrying higher loads of fungus.
Healthy individuals had low fungal loads, mostly poorly characterised Malasezziales.The
most common fungus in asthmatics was Aspergillus fumigatus complex and this taxon
accounted for the increased burden of fungus in the high level samples. Corticosteroid
treatment was significantly associated with increased fungal load (p<0.01).
Conclusions
The mycobiome is highly variable. Highest loads of fungus are observed in severe asthmatics
and the most common fungus is Aspergillus fumigatus complex. Individuals receiving steroid
therapy had significantly higher levels of Aspergillus and total fungus in their BAL.
Citation
allergic fungal disease. Journal of Allergy and Clinical Immunology, 142(2), 407-414. https://doi.org/10.1016/j.jaci.2017.09.039
Journal Article Type | Article |
---|---|
Acceptance Date | Sep 21, 2017 |
Online Publication Date | Nov 6, 2017 |
Publication Date | Nov 6, 2017 |
Deposit Date | Nov 29, 2017 |
Publicly Available Date | Mar 27, 2018 |
Journal | The Journal of Allergy and Clinical Immunology |
Print ISSN | 0091-6749 |
Publisher | Elsevier |
Volume | 142 |
Issue | 2 |
Pages | 407-414 |
DOI | https://doi.org/10.1016/j.jaci.2017.09.039 |
Publisher URL | http://dx.doi.org/10.1016/j.jaci.2017.09.039 |
Related Public URLs | http://www.jacionline.org/ |
Additional Information | Projects : FP7-2007-2013 Grant Number: MR/M02010 Grant Number: HEALTH-F2-2010-260338 ''ALLFUN.'' |
Files
G__Lucy 2017 HD_Salford work_Research_My publications_Bowyer-Smyth2017JACI.pdf
(1.8 Mb)
PDF
Version
Primary research article
corticosteroid treatment etc.pdf
(807 Kb)
PDF
Licence
http://creativecommons.org/licenses/by/4.0/
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/
You might also like
The effects of corticosteroids on cytokine production from asthma lung lymphocytes
(2014)
Journal Article
Role of regulatory T-cells in COPD
(2010)
Journal Article
Increased airway T regulatory cells in asthmatic subjects
(2010)
Journal Article
Identification of cells expressing Interleukin-17A and F in the lungs of COPD patients
(2010)
Journal Article
Downloadable Citations
About USIR
Administrator e-mail: library-research@salford.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search